Reviewed by the PeptideMind Team · Updated August 5, 2026

MOTS-c Peptide Dosage Calculator, Benefits & Side Effects

MOTS-c peptide dosage calculator plus research doses, dosing frequency & injection timing, and benefits for insulin sensitivity, brown fat activation, mitochondrial health, and side effects.

Basic Dosage Calculator

Calculate peptide doses with our visual syringe guide.

Peptide per vial

Target research quantity

Bac water added

As seen on

MOTS-c Dosage Schedule

A twice weekly protocol built around a mitochondrial derived peptide studied for supporting metabolic health and exercise capacity. Good for a multi month block focused on energy and training output.

MOTS-c Metabolic Support Protocol

10 weeks, focused on metabolic health.

2 days per week

Taken Monday and Thursday.

3.75 mg per injection

3.75 mg per injection, given just under the skin in the abdomen or thigh.

MOTS-c is a mitochondrial derived peptide studied for supporting metabolic health, insulin sensitivity, and exercise capacity. Weekly totals are typically split across two to three injections rather than given in one shot.

September 2026

Sun

Mon

Tue

Wed

Thu

Fri

Sat

What is MOTS-c?

MOTS-c is a peptide made inside your mitochondria, the energy-producing parts of your cells, making it one of a rare group of peptides that come from mitochondrial DNA rather than the regular genome. It acts almost like a stress hormone for your cells, helping regulate metabolism, blood sugar control, and how your body copes with physical stress. Researchers and longevity-focused clinicians study it for fighting age-related metabolic decline and supporting physical performance.

Longevity

Research targets include cellular aging, senescence, and long-term healthspan.

Metabolic

Research targets include glucose regulation, insulin sensitivity, and energy metabolism.

Metabolic

mot

Metabolic

Our top-rated vendor

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

Visit site

View all vendors

What Does MOTS-c Do?

It disrupts a metabolic pathway inside mitochondria in a way that switches on AMPK, the same 'low-fuel' master switch activated by exercise, prompting cells to burn more fat and take in more sugar for energy. Under stress, it can also travel into the cell's nucleus and help turn on genes involved in antioxidant defense and stress adaptation.

Disrupts mitochondria

Disrupts a metabolic pathway inside the cell's energy factories.

Switches on AMPK

Activates the same 'low-fuel' switch triggered by exercise.

Helps under stress

Can also turn on genes involved in antioxidant defense and stress adaptation.

Frequently Asked Questions About MOTS-c

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded in the mitochondrial genome rather than nuclear DNA. It is often called an 'exercise mimetic' because it activates the AMPK (AMP-activated protein kinase) pathway and the folate-AICAR-AMPK cycle, effects that closely resemble the metabolic changes produced by physical exercise. In research settings, MOTS-c has been shown to increase glucose uptake in skeletal muscle, improve insulin sensitivity, and translocate to the cell nucleus under stress to regulate genes involved in antioxidant and stress-adaptation responses. Endogenous MOTS-c levels rise substantially during exercise and stay elevated for hours afterward, which is part of why it draws interest for metabolic and longevity research.

Community and clinic-published protocols most commonly describe 5-10 mg administered subcutaneously, 2-3 times per week, for cycles of roughly 4-8 weeks. A common reconstitution is 10 mg of lyophilized peptide mixed with 1 mL of bacteriostatic water, yielding a 10 mg/mL solution (a 5 mg dose equals 0.5 mL, or 50 units on a standard U-100 insulin syringe). These figures come from vendor and community sources rather than an approved clinical label — there is no FDA-approved dose for MOTS-c, and any protocol numbers should be treated as informal reference points from research literature and user reports, not medical guidance.

MOTS-c is generally described as well tolerated in user reports. The most frequently mentioned effects are mild and transient: redness, itching, or minor bruising at the injection site; short-lived fatigue during the first one to two weeks of use; and occasional mild headache after early injections. Some users also report transient nausea, bloating, or digestive upset, and a subset describe flushing, skin redness, or hive-like reactions that are attributed to histamine/mast-cell release rather than a classic allergic response. Long-term human safety data are limited since MOTS-c has not gone through full clinical trials, so the actual side-effect profile beyond short-term anecdotal reports is not well established.

Lyophilized (powder) MOTS-c is typically stored refrigerated at 2-8°C, protected from light, and reportedly remains stable for 18-24 months refrigerated or longer when kept frozen at -20°C or below. Once reconstituted with bacteriostatic or sterile water, the solution is generally kept refrigerated (not frozen, since freezing liquid can shear peptide bonds) and is commonly used within 14-28 days for best potency. These are handling conventions repeated across vendor and community sources rather than a manufacturer-guaranteed shelf life, since MOTS-c is not a regulated pharmaceutical product with standardized stability data.

In the United States, MOTS-c is not FDA-approved for any medical use and is not a scheduled/controlled substance. It is widely sold labeled 'for research use only, not for human consumption,' meaning it cannot legally be marketed as a drug or supplement for personal use, even though it is not explicitly illegal to possess. Regulatory treatment can vary by country and is subject to change. Athletes should also note that MOTS-c is included on the World Anti-Doping Agency (WADA) prohibited list, both in and out of competition, so it is not a permissible substance in tested sports.

No. MOTS-c has not been approved by the FDA for any indication. Most of the supporting evidence comes from cell studies and animal models (notably mouse studies showing improved endurance, glucose tolerance, and insulin sensitivity), along with a smaller body of human observational research on endogenous MOTS-c levels during exercise. Large-scale, controlled human clinical trials on exogenous MOTS-c administration are limited, so claims about its effects in humans should be treated as preliminary and research-stage rather than established medical fact.

Yes, MOTS-c is frequently discussed alongside growth-hormone-secretagogue peptides such as CJC-1295 and Ipamorelin in metabolic-health and body-composition research contexts. The rationale given is that MOTS-c targets mitochondrial and insulin-sensitivity pathways ('bottom-up' cellular energy use) while CJC-1295/Ipamorelin stimulate the body's own growth hormone pulses ('top-down' signaling affecting recovery and sleep). This combination shows up often in vendor and clinic content, but it is an informal, evidence-thin practice rather than a studied or approved protocol, and combining peptides increases the number of unknowns around interactions and side effects.

Within the peptide research and biohacking community, MOTS-c is discussed mainly in the context of metabolic health (insulin sensitivity, glucose regulation), exercise performance and endurance, fat metabolism, and cellular aging/stress resistance. These interests stem from preclinical findings, such as MOTS-c improving running endurance and glucose tolerance in aged mice, rather than from confirmed benefits in human clinical use. As with other research peptides, any purported benefits for weight loss, longevity, or performance in humans remain unproven and should not be treated as established or guaranteed outcomes.

MOTS-c Reconstitution Guide

MOTS-c is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 10mg, 20mg, 40mg sizes.

10 mg lyophilized vial

MOTS-c is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 10mg, 20mg, 40mg sizes.

2 mL bacteriostatic water

Adding 2 mL of bac water to a 10 mg vial gives a workable concentration for syringe dosing. More water makes microdosing easier; less concentrates each draw.

Storage after mixing

Keep the dry powder well below freezing, in a dry environment. Once mixed with liquid, refrigerate for a few days or freeze it for longer, avoiding repeated freezing and thawing. After reconstitution, keep the vial refrigerated and use within 30 days.

Reconstitution steps

Remove caps & sanitize stoppers

Attach needle to syringe

Draw 2 mL bacteriostatic water

Insert needle into MOTS-c vial

Release water gently down the side

Swirl to dissolve — don't shake

Check for full dissolution

Refrigerate MOTS-c — good for 30 days

Chemical Makeup

Amino Acids

MOTS-c

Met

Position 1

Arg

Position 2

Trp

Position 3

Gln

Position 4

Glu

Position 5

Met

Position 6

Gly

Position 7

Tyr

Position 8

Ile

Position 9

Phe

Position 10

Tyr

Position 11

Pro

Position 12

Arg

Position 13

Lys

Position 14

Leu

Position 15

Arg

Position 16

Amino acid sequence

MethioninePosition 1

ArgininePosition 2

TryptophanPosition 3

GlutaminePosition 4

Glutamic acidPosition 5

MethioninePosition 6

GlycinePosition 7

TyrosinePosition 8

IsoleucinePosition 9

PhenylalaninePosition 10

TyrosinePosition 11

ProlinePosition 12

ArgininePosition 13

LysinePosition 14

LeucinePosition 15

ArgininePosition 16

What Are the Benefits of MOTS-c?

What research says it may help with, and how it works in the body.

metabolic

: In animal studies, it made the body about 30% better at responding to insulin, the hormone that moves sugar out of the blood, by switching on a key energy-sensing pathway in cells.
: Helps bring metabolism back to a healthier state by making cells more responsive to insulin.
: Encourages the body to burn more fat for fuel, even when calorie intake stays the same.

antiaging

: In animal studies, it reversed some of the physical decline that normally comes with aging.
: Improves the performance of mitochondria, the energy-producing parts of cells, by activating a master switch that builds more of them.
: Mice given this in studies lived about 6.4% longer on average.

exercise performance

: A single dose improved running performance by 12-15% in studies.
: Helps muscles recover and adapt after exercise.
: Exercise caused the body's own levels of this peptide in muscle tissue to rise almost 12-fold.

What Are the Side Effects of MOTS-c?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

: Limited long-term human safety data
: Pregnancy or breastfeeding
: WADA prohibited substance (banned for athletic competition)

Stop Right Away If You Notice

: Severe allergic reactions or anaphylaxis
: Recurrent hypoglycemia (<50 mg/dL)
: Persistent severe injection site reactions
: Unexplained weight loss >10% of baseline

Milder Signs to Watch For

Discolored powder or solutionCloudy solution after reconstitutionNo certificate of analysis available

Was it helpful?Yes

Is MOTS-c FDA approved?

MOTS-c is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

MOTS-c has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

A smartphone screen displaying FDA status for a drug, indicating "FDA approved drug: No" and "Classification: Research use only." A banner notes "Research Only" with the disclaimer "not for human use," emphasizing its intended use for laboratory and analytical purposes.

MOTS-c Cycle Length: How Long Should It Last?

This breaks down how long a typical MOTS-c cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Week 1-2: AMPK pathway activation; initial glucose tolerance improvements
Week 2-4: Enhanced exercise capacity; improved insulin sensitivity
Week 4-8: Sustained metabolic benefits; potential body composition changes
Week 8-12: Maximum mitochondrial function enhancement; metabolic flexibility